{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:29:50Z","timestamp":1793996990222,"version":"4.8.0"},"reference-count":39,"publisher":"Guilford Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Education and Prevention"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>The HIV Vaccine Trials Network (HVTN) is the largest publicly funded international collaboration facilitating the evaluation of vaccines to prevent HIV and TB. Central to the HVTN's success is the reliance on robust community engagement methods, ensuring community participation and facilitating community awareness and knowledge of research. Community engagement is a dynamic process that requires active participation from all stakeholders to ensure success. The HVTN and its global Clinical Research Sites (CRSs) located in Africa, Latin America, and North America are known as the Network. We describe relationships across the Network, specific staff roles and responsibilities, and the myriad activities undertaken to ensure optimal community engagement. Key activities include involving active Community Advisory Boards (CABs), using community consultations, and having trained Community Engagement staff at each CRS. Operating with robust community engagement has resulted in rapid enrollment and high retention of diverse participant populations across Network studies.<\/jats:p>","DOI":"10.1521\/aeap.2026.38.1.1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:23:35Z","timestamp":1772123015000},"page":"1-17","source":"Crossref","is-referenced-by-count":2,"title":["Building Trust and Engaging Communities for HIV Prevention Research Globally"],"prefix":"10.1521","volume":"38","author":[{"given":"Michele","family":"Andrasik","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Broder","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Louis","sequence":"additional","affiliation":[{"name":"Seattle Vaccine Trials Unit, Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kagisho","family":"Baepanye","sequence":"additional","affiliation":[{"name":"Hutchinson Centre Research Institute of South Africa (HCRISA)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Kamel","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Segura","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom","family":"Makhubalo","sequence":"additional","affiliation":[{"name":"The Aurum Institute."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariadel Rosario","family":"Leon Rhandomy","sequence":"additional","affiliation":[{"name":"Impacta Salud y Educacion Peru Clinical Trials Unit."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Soler","sequence":"additional","affiliation":[{"name":"New York Blood Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri Karas","family":"Certo","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Clinical Research Site."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waltana","family":"Dawit","sequence":"additional","affiliation":[{"name":"Seattle Vaccine Trials Unit, Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Reinstein","sequence":"additional","affiliation":[{"name":"Peru Clinical Trials Unit."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody E.","family":"Shipman","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linly","family":"Seyama","sequence":"additional","affiliation":[{"name":"Johns Hopkins Project Blantyre, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Sanchez Sarmiento","sequence":"additional","affiliation":[{"name":"El Centro de Investigaciones Tecnol\u00f3gicas, Biom\u00e9dicas y Medioambientales, Epicentro, Lima, Peru."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nombeko Cynthia","family":"Mpongo","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Foundation, Emavundleni Clinical Research Site."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Swann","sequence":"additional","affiliation":[{"name":"U.S. National Institute of Allergies and Infectious Diseases."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetha S.","family":"Morar","sequence":"additional","affiliation":[{"name":"South African Medical Research Council (SAMRC)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"377","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Abernethy, N. F., McCloskey, K., Trahey, M., Rinn, L., Broder, G. B., Andrasik, M., Laborde, R., McGhan, D., Spendolini, S., Marimuthu, S., Kanzmeier, A., Hanes, J. & Kublin, J. (2024). Rapid development of a regi stry to accelerate C OVID-19 vaccine clinical trials. Research Square, rs.3.rs-4397271. https:\/\/doi.org\/10.21203\/rs.3.rs-4397271\/v1","DOI":"10.1038\/s41746-025-01666-3"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0310-z"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258858"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301653"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.016"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002369"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11121-013-0371-0"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.301893"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239276"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4159\/9780674028845"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.926"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.576514"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231086"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jcop.22951"},{"issue":"1","key":"ref15","first-page":"65","volume":"28","author":"Donnermeyer J. F.","year":"1997","journal-title":"Community Development"},{"key":"ref16","volume-title":"Peer Navigation for Key Populations: Implementation Guide","author":"FHI 360\/Linkages","year":"2017"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.25.4.462"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37640"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05792-7"},{"key":"ref20","unstructured":"HANC. (2025). Recommendations for community engagement. Retreived October 7, 2025, from https:\/\/www.hanc.info\/resources\/sops-guidelines-resources\/community.html#community-engagement"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/0033354918814260"},{"key":"ref22","unstructured":"HVTN. (2025). Bill of Rights and Responsibilities (BRR) for HIV Research. Retrieved October 7, 2025, from https:\/\/www.hanc.info\/resources\/sops-guidelines-resources\/community.html#community-engagement"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4155\/cli.12.8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09785-0"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"ref26","first-page":"61","volume-title":"Community-based participatory research for health: Advancing social and health equity","author":"Lucero J. E.","year":"2017"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25179"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1089\/bio.2018.0136"},{"key":"ref29","unstructured":"National Institutes of Health. (2012). Clinical Trials Units for NIAID Networks (UM1). https:\/\/www.niaid.nih.gov\/research\/hivaids-clinical-trials-units-and-clinical-research-sites"},{"key":"ref30","unstructured":"Network HVT. (2024). Community overview. Retrieved October 30, 2024, from https:\/\/www.hvtn.org\/community\/community-overview.html"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.51.3.390"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/med:psych\/9780199845491.003.0034"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2103104"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/1359105311398727"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/1049732318812773"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.032"},{"key":"ref37","volume-title":"Good participatory practice guidelines for biomedical HIV prevention trials","author":"UNAIDS\/AVAC","year":"2007"},{"key":"ref38","volume-title":"Good participatory practice guidelines for biomedical HIV prevention trials","author":"UNAIDS\/AVAC","year":"2011","edition":"2"},{"key":"ref39","volume-title":"Community-based participatory research for health","author":"Wallerstein N.","year":"2018","edition":"3"}],"container-title":["AIDS Education and Prevention"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:24:17Z","timestamp":1772555057000},"score":1,"resource":{"primary":{"URL":"https:\/\/guilfordjournals.com\/doi\/10.1521\/aeap.2026.38.1.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1521\/aeap.2026.38.1.1"],"URL":"https:\/\/doi.org\/10.1521\/aeap.2026.38.1.1","relation":{},"ISSN":["0899-9546"],"issn-type":[{"value":"0899-9546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}